filmov
tv
Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC)

Показать описание
This animation provides an overview of several immunotherapy treatments that have been approved for non-small cell lung cancer (NSCLC). Immunotherapy is the use of medicines to stimulate the body's immune system to recognize and attack cancer cells. This animation also describes how your doctor will evaluate whether immunotherapy is right for you, possible treatment side effects, and clinical trials. It's important to discuss all treatment options with your doctor or cancer care team, so you can make the best decisions that are right for you. Side effects of immunotherapy are often treated with prednisone, a drug that suppresses your immune system. Your immunotherapy will be stopped until the side effects clear up.
Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC)
How Breakthroughs in Immunotherapy are Helping Non-Small Cell Lung Cancer Patients Live Longer
Immunotherapy in second-line treatment of non-small cell lung cancer
Targeted Therapy in Non-Small Cell Lung Cancer
Immunotherapy for Squamous Non-Small Cell Lung Cancer
Immunotherapy Treatments for Small Cell Lung Cancer (SCLC)
Non-Small Cell Lung Cancer (NSCLC) Immunotherapy: Advancing Hope
Treatment Process in Non–Small Cell Lung Cancer
Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
Understanding Immunotherapy for Lung Cancer
Is adjuvant immunotherapy necessary in non-small cell lung cancer?
The Basics of Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
Keeping Lung Cancer Under Control: Bob's Immunotherapy Story
Neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer
Small cell lung cancer may respond to combination of immunotherapy and targeted therapy
Going from Stage IV Lung Cancer to Clean Scans
Updates in early stage non-small cell lung cancer
Moving immunotherapy to earlier lines in NSCLC
Treatment Recommendations for Stage 3 Non-Small Cell Lung Cancer
Treating PD-L1-positive NSCLC with immunotherapy alone vs chemoimmunotherapy
Durvalumab Tolerability in Non–Small Cell Lung Cancer
Dr. Goldberg on Further Immunotherapy Trials in Non-Small Cell Lung Cancer
Lung Cancer Breakout: Breakthrough treatments for longer life
The Role of Immunotherapy in Non Small Cell Lung Cancer NSCLC
Комментарии